Charles Schwab’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.22B | Buy |
3,000,562
+74,971
| +3% | +$30.4M | 0.21% | 82 |
|
2025
Q1 | $1.46B | Buy |
2,925,591
+115,463
| +4% | +$57.5M | 0.27% | 64 |
|
2024
Q4 | $1.46B | Buy |
2,810,128
+366,191
| +15% | +$191M | 0.27% | 59 |
|
2024
Q3 | $1.51B | Buy |
2,443,937
+61,017
| +3% | +$37.7M | 0.29% | 56 |
|
2024
Q2 | $1.32B | Buy |
2,382,920
+34,501
| +1% | +$19.1M | 0.25% | 71 |
|
2024
Q1 | $1.36B | Buy |
2,348,419
+71,153
| +3% | +$41.4M | 0.32% | 54 |
|
2023
Q4 | $1.21B | Buy |
2,277,266
+92,338
| +4% | +$49M | 0.31% | 60 |
|
2023
Q3 | $1.11B | Buy |
2,184,928
+8,672
| +0.4% | +$4.39M | 0.32% | 55 |
|
2023
Q2 | $1.14B | Sell |
2,176,256
-15,340
| -0.7% | -$8M | 0.32% | 53 |
|
2023
Q1 | $1.26B | Buy |
2,191,596
+38,612
| +2% | +$22.3M | 0.38% | 41 |
|
2022
Q4 | $1.19B | Buy |
2,152,984
+62,495
| +3% | +$34.4M | 0.38% | 45 |
|
2022
Q3 | $1.06B | Buy |
2,090,489
+30,253
| +1% | +$15.3M | 0.38% | 49 |
|
2022
Q2 | $1.12B | Buy |
2,060,236
+14,667
| +0.7% | +$7.97M | 0.39% | 47 |
|
2022
Q1 | $1.21B | Buy |
2,045,569
+32,043
| +2% | +$18.9M | 0.36% | 45 |
|
2021
Q4 | $1.34B | Buy |
2,013,526
+47,206
| +2% | +$31.5M | 0.4% | 42 |
|
2021
Q3 | $1.12B | Buy |
1,966,320
+21,189
| +1% | +$12.1M | 0.37% | 53 |
|
2021
Q2 | $981M | Buy |
1,945,131
+47,449
| +3% | +$23.9M | 0.33% | 60 |
|
2021
Q1 | $866M | Buy |
1,897,682
+14,398
| +0.8% | +$6.57M | 0.32% | 61 |
|
2020
Q4 | $877M | Sell |
1,883,284
-32,193
| -2% | -$15M | 0.35% | 53 |
|
2020
Q3 | $846M | Buy |
1,915,477
+48,950
| +3% | +$21.6M | 0.39% | 50 |
|
2020
Q2 | $676M | Sell |
1,866,527
-10,874
| -0.6% | -$3.94M | 0.33% | 56 |
|
2020
Q1 | $532M | Buy |
1,877,401
+5,459
| +0.3% | +$1.55M | 0.31% | 63 |
|
2019
Q4 | $608M | Buy |
1,871,942
+26,617
| +1% | +$8.65M | 0.33% | 52 |
|
2019
Q3 | $537M | Buy |
1,845,325
+48,566
| +3% | +$14.1M | 0.32% | 56 |
|
2019
Q2 | $528M | Buy |
1,796,759
+40,204
| +2% | +$11.8M | 0.32% | 55 |
|
2019
Q1 | $481M | Buy |
1,756,555
+119,201
| +7% | +$32.6M | 0.31% | 61 |
|
2018
Q4 | $366M | Buy |
1,637,354
+42,021
| +3% | +$9.4M | 0.28% | 65 |
|
2018
Q3 | $389M | Buy |
1,595,333
+28,770
| +2% | +$7.02M | 0.26% | 70 |
|
2018
Q2 | $324M | Buy |
1,566,563
+46,519
| +3% | +$9.64M | 0.24% | 74 |
|
2018
Q1 | $314M | Sell |
1,520,044
-8,536
| -0.6% | -$1.76M | 0.24% | 70 |
|
2017
Q4 | $290M | Sell |
1,528,580
-42,085
| -3% | -$7.99M | 0.23% | 74 |
|
2017
Q3 | $297M | Buy |
1,570,665
+33,606
| +2% | +$6.36M | 0.26% | 63 |
|
2017
Q2 | $268M | Buy |
1,537,059
+135,068
| +10% | +$23.6M | 0.25% | 66 |
|
2017
Q1 | $215M | Buy |
1,401,991
+48,941
| +4% | +$7.52M | 0.22% | 80 |
|
2016
Q4 | $191M | Buy |
1,353,050
+35,121
| +3% | +$4.96M | 0.21% | 84 |
|
2016
Q3 | $210M | Buy |
1,317,929
+49,886
| +4% | +$7.93M | 0.25% | 66 |
|
2016
Q2 | $187M | Buy |
1,268,043
+159,131
| +14% | +$23.5M | 0.23% | 70 |
|
2016
Q1 | $157M | Buy |
1,108,912
+57,709
| +5% | +$8.17M | 0.21% | 89 |
|
2015
Q4 | $149M | Buy |
1,051,203
+39,952
| +4% | +$5.67M | 0.2% | 93 |
|
2015
Q3 | $124M | Buy |
1,011,251
+24,034
| +2% | +$2.94M | 0.18% | 109 |
|
2015
Q2 | $128M | Buy |
987,217
+13,215
| +1% | +$1.71M | 0.18% | 109 |
|
2015
Q1 | $131M | Buy |
974,002
+40,944
| +4% | +$5.5M | 0.18% | 108 |
|
2014
Q4 | $117M | Buy |
933,058
+47,190
| +5% | +$5.91M | 0.18% | 118 |
|
2014
Q3 | $108M | Buy |
885,868
+21,625
| +3% | +$2.63M | 0.18% | 118 |
|
2014
Q2 | $102M | Sell |
864,243
-187,373
| -18% | -$22.1M | 0.17% | 117 |
|
2014
Q1 | $126M | Buy |
1,051,616
+114,316
| +12% | +$13.7M | 0.23% | 84 |
|
2013
Q4 | $104M | Sell |
937,300
-682,909
| -42% | -$76M | 0.2% | 105 |
|
2013
Q3 | $150M | Sell |
1,620,209
-318,892
| -16% | -$29.6M | 0.31% | 63 |
|
2013
Q2 | $167M | Buy |
+1,939,101
| New | +$167M | 0.37% | 47 |
|